Low-frequency CD8+ T cells induced by SIGN-R1+ macrophage-targeted vaccine confer SARS-CoV-2 clearance in mice
Vaccine-induced T cells and neutralizing antibodies are essential for protection against SARS-CoV-2. Previously, we demonstrated that an antigen delivery system, pullulan nanogel (PNG), delivers vaccine antigen to lymph node medullary macrophages and thereby enhances the induction of specific CD8<sup>+</sup> T cells. In this study, we revealed that medullary macrophage-selective delivery by PNG depends on its binding to a C-type lectin SIGN-R1. In a K18-hACE2 mouse model of SARS-CoV-2 infection, vaccination with a PNG-encapsulated receptor-binding domain of spike protein decreased the viral load and prolonged the survival in the CD8<sup>+</sup> T cell- and B cell-dependent manners. T cell receptor repertoire analysis revealed that although the vaccine induced T cells at various frequencies, low-frequency specific T cells mainly promoted virus clearance. Thus, the induction of specific CD8<sup>+</sup> T cells that respond quickly to viral infection, even at low frequencies, is important for vaccine efficacy and can be achieved by SIGN-R1<sup>+</sup> medullary macrophage-targeted antigen delivery.
Authors
- Hiroaki Ikeda (ORCID: https://orcid.org/0000-0002-8012-4796)
- Chieko Takashima
- Meng Ling Moi (ORCID: https://orcid.org/0000-0002-8103-6659)
- Takaaki Nakatsukasa
- Daisuke Muraoka (ORCID: https://orcid.org/0000-0002-4493-7052)
- Yasunari Haseda
- Shin‐ichi Sawada (ORCID: https://orcid.org/0000-0003-1051-696X)
- Kazunari Akiyoshi (ORCID: https://orcid.org/0000-0003-2434-3385)
- Rui Yamaguchi (ORCID: https://orcid.org/0000-0003-1224-227X)
- Hirokazu Matsushita (ORCID: https://orcid.org/0000-0001-9069-7160)
- Thi Thanh Ngan Nguyen (ORCID: https://orcid.org/0000-0003-0819-5263)
- Osamu Muto (ORCID: https://orcid.org/0000-0003-3831-7612)
- Situo Deng
- Naozumi Harada
- Takatoshi Soga
- Haruka Hayakawa
Institutions
- Kyoto University (JP)
- Chiba University Hospital (JP)
- Aichi Cancer Center (JP)
- Department of Health (IE)
- ImmunityBio (United States) (US)
- Nagasaki University (JP)
- Nagoya University (JP)
Publication Details
- Journal
- npj Vaccines
- Published
- 2024-09-18
- DOI
- https://doi.org/10.1038/s41541-024-00961-6
- Citations
- 3
- Primary Topic
- SARS-CoV-2 and COVID-19 Research
- Type
- article
- Field-Weighted Citation Impact
- 1.17
Funders
- Japan Agency for Medical Research and Development